NCT02666209 2017-08-28Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple MyelomaDana-Farber Cancer InstituteNo longer available
NCT01359657 2016-03-16Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple MyelomaBristol-Myers SquibbPhase 1 Completed46 enrolled